- Leadership at the Centre of Africa’s Investment Story
- Delisting and take-private trend is a sign of progress rather than crisis for South Africa
- Energy: The Cornerstone of Africa's Infrastructure Development
- Powering Africa's Industrialisation Through Energy and Infrastructure Development
- Will AI disrupt the payments industry in 2026? Izak van Heerden, Senior Manager: Development at Altron FinTech
Big Pharma Looks Beyond Covid With AstraZeneca Eyeing Gilead
NEW YORK (Capital Markets in Africa) — Two drugmakers behind the industry’s most prominent responses to the Covid-19 pandemic are looking into the possibility of a combined future as economies emerge from lockdowns. AstraZeneca Plc, co-developer of one of the fastest-moving experimental coronavirus vaccines, has made a preliminary approach to Gilead Sciences Inc., maker of the only U.S.-approved treatment, according to people familiar with the matter. If they decided to pursue a merger, it would be…
Read More







